France’s Stilla Technologies lands $18 mln in Series A financing round

French biotechnology company Stilla Technologies has landed 16 million euros ($18 million) in Series A financing round.

Stilla Technologies plans to use the capital raised to accelerate the sales of its Naica System, launch its second generation solution and start clinically validating panels to be run on the system, with an initial focus in the field of oncology.

Led by U.S.-based private equity firm Illumina Ventures, the funding round had participation from peers France's Kurma Partners, LBO France, BNP Paribas Développement, Paris Saclay Seeds and Idinvest Partners.

In conjunction with the funding, Illumina Ventures, Kurma Partners and LBO France will join Stilla Technologies’ board of directors.